Heidelberg Pharma AG HPHA-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR
Last | 4:59 PM CET
8.36quote price arrow up+0.14 (+1.70%)
Volume
617
52 week range
2.13 - 9.70

...

Loading . . .

KEY STATS

  • Open8.26
  • Day High8.70
  • Day Low8.26
  • Prev Close8.22
  • 52 Week High9.70
  • 52 Week High Date02/18/21
  • 52 Week Low2.13
  • 52 Week Low Date03/02/20
  • Market Cap321.38M
  • Shares Out31.05M
  • 10 Day Average Volume50,579.18
  • Dividend-
  • Dividend Yield-
  • Beta-1.33
  • 1 Year % Change244.03

RATIOS/PROFITABILITY

  • EPS (TTM)-0.59
  • P/E (TTM)-14.17
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Heidelberg Pharma AG News

There is no recent news for this security.

Latest HPHA-FF News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Heidelberg Pharma AG, formerly Wilex AG, is a Germany-based company engaged in the biopharmaceuticals sector. The Company focuses on the research and development of therapy treatments for oncology area. It aims at applying toxin Amanitin into cancer therapies using its Antibody Targeted Amanitin Conjugate (ATAC) technology. The Company’s pipeline includes a number of drug candidates, such as HDP-101, a B-cell maturation antigen ATAC for multiple myeloma; PSMA-ATAC...
Address
Schriesheimer Strasse 101
Ladenburg
68526
Germany